06.02.2026; Чернівці, Україна: XI Міжнародна наукова конференція «Технології, інструменти та стратегії реалізації наукових досліджень»
Роботи, що індексуються в Google Scholar

ASSESSMENT OF COGNITIVE FUNCTIONS IN PATIENTS WITH ARTERIAL HEPERTENSION IN FAMILY PHYSICIAN PRACTICE

  • Oleksandr Soloviov,
  • Andrii Bezborodov
DOI: https://doi.org/10.62731/mcnd-06.02.2026.009
PDF

Опубліковано 12.02.2026

Як цитувати

Soloviov, O., & Bezborodov, A. (2026). ASSESSMENT OF COGNITIVE FUNCTIONS IN PATIENTS WITH ARTERIAL HEPERTENSION IN FAMILY PHYSICIAN PRACTICE. Матеріали конференцій МЦНД, (06.02.2026; Чернівці, Україна), 224–229. https://doi.org/10.62731/mcnd-06.02.2026.009

Завантаження

Дані завантаження ще не доступні.

Авторське право (c) 2026 Oleksandr Soloviov, Andrii Bezborodov

Creative Commons License

Ця робота ліцензується відповідно до Creative Commons Attribution-ShareAlike 4.0 International License.

Google Scholar

Анотація

Arterial hypertension (AH) is one of the most prevalent chronic diseases and requires long-term patient follow-up under the medical supervision of a family physician. Although scientific attention is often focused on preventing acute cardiovascular events such as stroke or myocardial infarction, the impact of chronically elevated blood pressure (BP) on cognitive function represents a much deeper problem than previously believed. Elevated BP is recognized as a well-established and modifiable risk factor for age-related cognitive
decline.

PDF

Посилання

  1. 1. Pacholko A, Iadecola C. Hypertension, neurodegeneration, and cognitive decline. Hypertension. 2024; 81(5): 991-1007. DOI: 10.1161/HYPERTENSIONAHA.123.21356.
  2. 2. Gerasimenko L, Sid E, Lychko V. Characteristics of changes in cognitive functions of the patients with hypertensive disease. Georgian medical news. 2017; 272: 80-86. DOI: 10.5281/zenodo.17559816.
  3. 3. Sid EV. Psychological characteristics of geriatric patients seeking emergency medical care. Modern medical technology. 2018; 1: 96-101. DOI: 10.5281/zenodo.17560904.
  4. 4. Theofilis P, Doumani G, Tsatsani GC, et al. The role of hypertension in cognitive dysfunction. Journal of clinical medicine. 2024; 13(19): 5979. DOI: 10.3390/jcm13195979.
  5. 5. Gettel C, Galske J, Araujo K, et al. Detection and differentiation of undiagnosed dementia in the emergency department: A pilot referral pathway. Alzheimer's & Dementia. 2025; 21(4): e70189. DOI: 10.1002/alz.70189.
  6. 6. Militaru M, Rachieru C, Lighezan DF, et al. The impact of hypertension and atrial fibrillation on cognitive decline and subclinical atherosclerosis. Brain Sciences. 2021; 11(6): 752. DOI: 10.3390/brainsci11060752.
  7. 7. Canavan M, O'Donnell MJ. Hypertension and cognitive impairment: a review of mechanisms and key concepts. Frontiers in Neurology. 2022; 13: 821135. DOI: 10.3389/fneur.2022.821135.
  8. 8. Levine DA, Springer MV, Brodtmann A. Blood pressure and vascular cognitive impairment. Stroke. 2022; 53(4): 1104-1113. DOI: 10.1161/STROKEAHA.121.036140.
  9. 9. Hainsworth AH, Markus HS, Schneider JA. Cerebral small vessel disease, hypertension, and vascular contributions to cognitive impairment and dementia. Hypertension. 2024; 81(1): 75-86. DOI: 10.1161/HYPERTENSIONAHA.123.19943.
  10. 10. Santisteban MM, Iadecola C, Carnevale D. Hypertension, neurovascular dysfunction, and cognitive impairment. Hypertension. 2023; 80(1): 22-34. DOI: 10.1161/HYPERTENSIONAHA.122.18085.
  11. 11. Yaffe K. Prevention of cognitive impairment with intensive systolic blood pressure control. Jama. 2019; 321(6): 548-549. DOI: 10.1001/jama.2019.0008.
  12. 12. Joyce OC, McHugh C, Mockler D, et al. Midlife hypertension is a risk factor for some, but not all, domains of cognitive decline in later life: a systematic review and meta-analysis. Journal of Hypertension. 2024; 42(2): 205-223. DOI: 10.1097/HJH.0000000000003614.
  13. 13. De Anda-Duran I, Woltz SG, Bell CN, et al. Hypertension and cognitive function: a review of life-course factors and disparities. Current opinion in cardiology. 2022; 37(4): 326-333. DOI: 10.1097/HCO.0000000000000975.
  14. 14. Kulbachuk OS, Sid YV, Soloviov OV, et al. The clinical role of daily blood pressure monitoring for the management of patients at the ambulatory stage. Modern medical technology. 2025; 17(2): 147-151. DOI: 10.14739/mmt.2025.2.324147.
  15. 15. Sible IJ, Nation DA. 24-hour blood pressure variability via ambulatory monitoring and risk for probable dementia in the SPRINT trial. The Journal of Prevention of Alzheimer's Disease. 2024; 11(3): 684-692. DOI: 10.14283/jpad.2024.35.
  16. 16. Patnode CD, Perdue LA, Rossom RC, et al. Screening for cognitive impairment in older adults: updated evidence report and systematic review for the US Preventive Services Task Force. Jama. 2020; 323(8): 764-785.
  17. 17. Seitz DP, Chan CC, Newton HT, et al. Mini‐Cog for the detection of dementia within a primary care setting. Cochrane Database of Systematic Reviews. 2021; 7: CD011415. DOI: 10.1002/14651858.CD011415.pub3.
  18. 18. Jia X, Wang Z, Huang F, et al. A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study. BMC psychiatry. 2021; 21(1): 485. DOI: 10.1186/s12888-021-03495-6.
  19. 19. Webb AJ, Pendlebury ST, Li L, et al. Validation of the MoCA versus MMSE against hypertension and hypertensive arteriopathy after TIA or minor stroke. Stroke; a journal of cerebral circulation. 2014; 45(11): 3337-3342. DOI:10.1161/STROKEAHA.114.006309.
  20. 20. Salvadori E, Poggesi A, Pracucci G, et al. Longitudinal changes in MoCA performances in patients with mild cognitive impairment and small vessel disease. Results from the VMCI-Tuscany Study. Cerebral Circulation-Cognition and Behavior. 2021; 2: 100008. DOI: 10.1016/j.cccb.2021.100008.